2026-01-12 - Analysis Report
**Company Overview**
Intuitive Surgical Inc, a leader in robotic surgery, has provided high-growth prospects for its investors.

**Return Rate Comparison**
| Ticker | Cumulative Return |
| --- | --- |
| ISRG | **86.24%** |
| VOO | **94.03%** |

Divergence: -7.80, Current relative divergence: 33.00%. The company has a moderate divergence with the S&P 500.

**Alpha, Beta Analysis Table**
| Period | CAGR | MDD | Alpha | Beta | Market Cap |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | **49.0%** | **29.0%** | **45.0%** | 1.2 | **$57.2B** |
| 2017-2019 | **40.0%** | **29.0%** | **23.0%** | 1.4 | **$70.6B** |
| 2018-2020 | -**8.0%** | **29.0%** | -**29.0%** | 1.2 | **$97.8B** |
| 2019-2021 | **26.0%** | **21.1%** | -**17.0%** | 1.2 | **$128.8B** |
| 2020-2022 | -**18.0%** | **48.9%** | -**16.0%** | 1.2 | **$95.1B** |
| 2021-2023 | -**12.0%** | **48.9%** | -**13.0%** | 1.4 | **$120.9B** |
| 2022-2024 | **35.0%** | **38.0%** | **16.0%** | 1.3 | **$187.1B** |
| 2023-2025 | **60.0%** | **28.0%** | -**2.0%** | 1.2 | **$203.0B** |

**Recent Sma Fluctuations**
| | Close | Last-Market | 5-day SMA | 20-day SMA | 60-day SMA |
| --- | --- | --- | --- | --- | --- |
|  | **$586.24** | **0.2** | **$584.56** | **$570.32** | **$552.32** |

**RSI, PPO Index Indicators**
| | RSI | PPO | Hybrid Signal | Risk Level | Recent Relative Divergence Change | 7-day Rank Change | 7-day Dynamic Expected Return Change |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  | **65.83** | **0.16** | Buy | Medium | (+) 3.80 | (+) 5 | (-) 0.50 |

**Expected Return**
3.80%

**Recent Fluctuation Issue**
Sharp rebound.

**Expected Excess Return**
3.80%

**News & Significant Events**
No recent analysis was provided in the prompt

    Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): 608.26 / 740.00 / 378.00

**Recent Earnings Analysis Table**
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-22 | **$1.98** | **$2.51B** |
| 2025-07-23 | **$1.84** | **$2.44B** |
| 2025-04-23 | **$1.95** | **$2.25B** |
| 2024-10-18 | **$1.59** | **$2.04B** |
| 2025-10-22 | **$1.59** | **$2.04B** |

Revenue and EPS trend is steady. 

**Revenue and Profitability Table**
| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | **$2.51B** | **66.36%** |
| 2025-06-30 | **$2.44B** | **66.31%** |
| 2025-03-31 | **$2.25B** | **64.69%** |
| 2024-12-31 | **$2.41B** | **68.04%** |
| 2024-09-30 | **$2.04B** | **67.41%** |

Profit margin trend is stable.

**Capital and Profitability Table**
| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | **$16.93B** | **4.16%** |
| 2025-06-30 | **$17.85B** | **3.69%** |
| 2025-03-31 | **$17.11B** | **4.08%** |
| 2024-12-31 | **$16.43B** | **4.17%** |
| 2024-09-30 | **$15.58B** | **3.63%** |

**Equity and ROE Trend Analysis**
Trend for equity is an increase and ROE is somewhat stable.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.